CD79A and necrotizing enterocolitis: However, based on a recent Cochrane Review of three randomized trials, there is no protective role against NEC with the oral administration of immunoglobulins in the neonatal period, specifically with IgG or a combination of IgG/IgA, as these studies did not demonstrate a significant reduction in NEC incidence (195–198).